| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Veradigm Inc. | Director | Common Stock | 56,624 | $243,483 | $4.30 | 02 Jun 2025 | Direct |
| Oncocyte Corp | Director | Common Stock, no par value | 36,564 | $96,528 | $2.64 | 01 Jul 2025 | Direct |
| STAAR SURGICAL CO | Director | Common Stock | 475 | $8,374 | $17.63 | 24 Apr 2025 | Direct |
| Oncocyte Corp | Director | Option to Purchase Common Stock | 30,000 | 01 Jul 2024 | Direct | ||
| STAAR SURGICAL CO | Director | Restricted Stock Units | 10,683 | 18 Jun 2025 | Direct | ||
| STAAR SURGICAL CO | Director | Common Stock Options | 2,440 | 12 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IMDX | Insight Molecular Diagnostics Inc. | 01 Jul 2025 | 1 | $0 | 4 | Director | 03 Jul 2025, 16:05 |
| STAA | STAAR SURGICAL CO | 18 Jun 2025 | 1 | $0 | 4 | Director | 20 Jun 2025, 17:23 |
| MDRX | Veradigm Inc. | 02 Jun 2025 | 1 | +$200,002 | 4 | Director | 03 Jun 2025, 19:45 |
| STAA | STAAR SURGICAL CO | 12 May 2025 | 1 | $0 | 4 | Director | 13 May 2025, 18:04 |
| STAA | STAAR SURGICAL CO | 24 Apr 2025 | 0 | $0 | 3 | Director | 29 Apr 2025, 17:00 |
| MDRX | Veradigm Inc. | 24 Mar 2025 | 1 | $0 | 4 | Director | 26 Mar 2025, 20:44 |
| MDRX | Veradigm Inc. | 20 Feb 2025 | 0 | $0 | 3 | Director | 26 Feb 2025, 17:00 |
| OCX | Oncocyte Corp | 01 Jul 2024 | 1 | $0 | 4 | Director | 03 Jul 2024, 21:00 |
| OCX | Oncocyte Corp | 23 Jun 2023 | 2 | $0 | 4 | Director | 27 Jun 2023, 21:30 |
| OCX | Oncocyte Corp | 30 Nov 2022 | 0 | $0 | 3 | Director | 09 Dec 2022, 19:21 |
| STAA | STAAR SURGICAL CO | 10 Aug 2021 | 9 | -$4,083,361 | 4 | Director | 12 Aug 2021, 16:21 |
| STAA | STAAR SURGICAL CO | 24 Jun 2021 | 1 | $0 | 4 | Director | 25 Jun 2021, 17:56 |